Despite upbeat earnings news, the markets traded mixed during the midday with the Dow losing 28 points to 11,117 over renewed concerns of a global currency war. Nasdaq gained 16 points to 2475.
On the upside
Third quarter earnings for Riverbed Technology (Nasdaq: RVBD) more than doubled to beat analyst expectations as revenue surged and the company announced a 2-for-1 stock split.
Shares of Arena Pharmaceuticals (Nasdaq: ARNA) rose ahead of the Food and Drug Administration's decision on the biopharmaceutical's weight loss treatment Iorcaserin.
Brookdale Senior Living (NYSE: BKD) stock climbed after rival senior living community operator Atria sold some properties to real estate investment trust Ventas.
On the downside
Bucyrus (Nasdaq: BUCY) disappointed with lower third quarter earnings that missed expectations as underground mining original equipment sales fell.
Third quarter earnings slipped for Leggett & Platt (NYSE: LEG) to fall short of analyst expectations.
Although third quarter earnings for Cytec Industries (NYSE: CYT) tripled, the results missed estimates.
In the broad market, advancing issues outpaced decliners by a margin of more than 10 to 9 on the NYSE and by 9 to 7 on Nasdaq. The Russell 2000 which tracks small cap stocks added 3 points to 701.
